Cell and Gene Therapy


Discover our Immunoassays services including ELISA, flow cytometry, and neutralizing antibody assays all customized for your specific testing and data collection needs.

We offer a wide range of trusted, precise, and accurate immunoassays services

Let Noble Life Sciences’ unparalleled expertise and state-of-the-art facilities be your trusted partner for all of your preclinical biodistribution and shedding studies. We have worked with xx organizations to bring xx new therapies to market.

Immunoassay Capabilities

Enzyme-linked immunosorbent assays (ELISAs) are a proven gene therapy technology. Noble can be your trusted partner for all ELISA cell and gene therapies that are required for your emerging therapy.

ELISAs are able to deliver precise, quantitative antibody-based measurements for cell and gene targets for which there is a sensitive and specific binding reagent.

Noble offers ELISA development services to support pre-clinical through phase 3 studies, including assay development or transfer, validation, and implementation.

Whether your therapy needs require ELISA services for cytokines and chemokines or flow cytometry and specific immune cell analysis, Noble’s professional lab scientists are able to provide a wide range of trusted, precise and accurate cell and gene therapy immunoassays services that can be customized for your specific testing and data collection needs.


  • Enzyme-linked immunosorbent assays (ELISA)
  • ELISA for Cytokines and chemokines
  • Flow Cytometry
  • Antigen-specific CD8 T cells in Splenocytes
  • Specific immune cell analysis in PBMC and Spleen
  • Antibody titering by ELISA (this is not for Oncology)

Explore other areas of expertise

How Our Team Can Help

With decades of GLP experience, our scientists can support all aspects of the GLP process, from design to regulatory support of your IND, IDE, or PMA FDA submission.

Arundhati Ghosh, Ph.D., MSc

Arundhati Ghosh, Ph.D., MSc

Study Director

Pang-Kuo Lo, Ph.D. MSc

Pang-Kuo Lo, Ph.D. MSc

Team Lead, Assay Development

Todd Parsley, Ph.D.

Todd Parsley, Ph.D.

Director, Infectious Diseases